Mette Skalshoi Kjaer
Overview
Explore the profile of Mette Skalshoi Kjaer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Younossi Z, Mangla K, Berentzen T, Grau K, Kjaer M, Ladelund S, et al.
Hepatol Commun
. 2024 May;
8(6).
PMID: 38727678
Background: Few studies have examined the risk of long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis in relation to liver histology. We aimed to study this using a real-world...
2.
Skat-Rordam P, Eliasson J, Kjaer M, Jeppesen P, Ytting H
Minerva Gastroenterol (Torino)
. 2023 Jun;
70(3):281-290.
PMID: 37326627
Background: The impact of primary biliary cholangitis (PBC) on health-related quality of life (HRQOL) is poorly understood. The aim of this study was to compare HRQOL in Danish patients with...
3.
Loomba R, Abdelmalek M, Armstrong M, Jara M, Kjaer M, Krarup N, et al.
Lancet Gastroenterol Hepatol
. 2023 Mar;
8(6):511-522.
PMID: 36934740
Background: Patients with non-alcoholic steatohepatitis (NASH)-related cirrhosis are at high risk of liver-related and all-cause morbidity and mortality. We investigated the efficacy and safety of the glucagon-like peptide-1 analogue semaglutide...
4.
Savic D, Mozes F, Green P, Burrage M, Kjaer M, Hodson L, et al.
Magn Reson Med
. 2022 Dec;
89(4):1314-1322.
PMID: 36573435
Purpose: Acetylcarnitine can be assessed in vivo using proton MRS ( H-MRS) with long TEs and this has been previously applied successfully in muscle. The aim of this study was...
5.
Nielsen J, Kjaer M, Rasmussen A, Chiranth D, Willemoe G, Henriksen B, et al.
Diagnostics (Basel)
. 2022 Nov;
12(11).
PMID: 36428845
Background: Elastography can be measured with different imaging techniques and is increasingly used for noninvasive assessment of hepatic fibrosis. Little is known about the performance, and interrelation of different elastographic...
6.
Alkhouri N, Herring R, Kabler H, Kayali Z, Hassanein T, Kohli A, et al.
J Hepatol
. 2022 Apr;
77(3):607-618.
PMID: 35439567
Background & Aims: Non-alcoholic steatohepatitis (NASH) is associated with increased risk of liver-related and cardiovascular morbidity and mortality. Given the complex pathophysiology of NASH, combining therapies with complementary mechanisms may...
7.
Nielsen J, Nerup N, Moller S, de Nijs R, Rasmussen A, Svendsen L, et al.
Scand J Gastroenterol
. 2019 Mar;
54(4):485-491.
PMID: 30924709
Pediatric liver disease (PLD) covers a variety of etiologies and severities, from mild temporary illness to diseases with fatal outcomes. There is a demand for minimally invasive and reliable measures...
8.
Nielsen J, Christensen V, Borgwardt L, Rasmussen A, Ostrup O, Kjaer M
Biochim Biophys Acta Mol Basis Dis
. 2018 Dec;
1865(3):577-586.
PMID: 30582966
Pediatric liver disease (PLD) is a major cause of severe morbidity and prolonged hospitalizations in children. Stratifying patients in terms of prognosis remains challenging. The limited knowledge about molecular mechanisms...
9.
Honore L, Kjaer T, Kjaer M
Clin Res Hepatol Gastroenterol
. 2018 Jul;
42(6):e97-e99.
PMID: 30049510
No abstract available.
10.
Dalgard O, Weiland O, Noraberg G, Karlsen L, Heggelund L, Farkkila M, et al.
PLoS One
. 2017 Jul;
12(7):e0179764.
PMID: 28704381
Background And Aims: Chronic hepatitis C virus (HCV) genotype 3 infection with advanced liver disease has emerged as the most challenging to treat. We retrospectively assessed the treatment outcome of...